A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions. (2017)

First Author: Opriessnig T
Attributed to:  Host responses underlying immunity funded by BBSRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2016.11.085

PubMed Identifier: 27919634

Publication URI: http://europepmc.org/abstract/MED/27919634

Type: Journal Article/Review

Volume: 35

Parent Publication: Vaccine

Issue: 2

ISSN: 0264-410X